AGIO Price / Book | AGIOS PHARMACEUTICALS, INC.

AGIOS PHARMACEUTICALS, INC. (AGIO) Price / Book

2026-09-03: Price/Book Ratio 1.93.
2026-06-30: Price/Book Ratio 2.16.
2026-03-31: Price/Book Ratio 1.81.
2025-12-31: Price/Book Ratio 1.33.

Historical market capitalization divided by filed shareholder equity.

Available history: 2013-09-30 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	1.93
2026-06-30	2.16
2026-03-31	1.81
2025-12-31	1.33
2025-09-30	1.82
2025-06-30	1.41
2025-03-31	1.16
2024-12-31	1.22
2024-09-30	1.56
2024-06-30	3.71
2024-03-31	2.23
2023-12-31	1.54
2023-09-30	1.56
2023-06-30	1.64
2023-03-31	1.23
2022-12-31	1.4
2022-09-30	1.48
2022-06-30	1.08
2022-03-31	1.32
2021-12-31	1.38
2021-09-30	1.81
2021-06-30	1.92
2021-03-31	1.57
2020-12-31	7.52
2020-09-30	5.04
2020-06-30	6.61
2020-03-31	3.9
2019-12-31	5.1
2019-09-30	4.26
2019-06-30	5.5
2019-03-31	6.38
2018-12-31	3.9
2018-09-30	5.9
2018-06-30	5.93
2018-03-31	5.44
2017-12-31	7.43
2017-09-30	7.21
2017-06-30	4.89
2017-03-31	8.05
2016-12-31	4.91
2016-09-30	5.53
2016-06-30	5.51
2016-03-31	4.63
2015-12-31	7.09
2015-09-30	7.07
2015-06-30	10.28
2015-03-31	8.24
2014-12-31	9.8
2014-09-30	10.23
2014-06-30	7.87
2014-03-31	10.27
2013-12-31	5.68
2013-09-30	6.09

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Sarepta Therapeutics, Inc. (SRPT)	United States	$1.941B	-13.89
Biohaven Ltd. (BHVN)	United States	$1.990B	-3.83
Nuvation Bio Inc. (NUVB)	United States	$2.007B	-13.12
UroGen Pharma Ltd. (URGN)		$2.015B	-18.42
Zymeworks Inc. (ZYME)	United States	$1.902B	-12.44
NEKTAR THERAPEUTICS (NKTR)	United States	$2.026B	-9.05
PERRIGO Co plc (PRGO)	Ireland	$2.038B	-0.79
Generate Biomedicines, Inc. (GENB)	United States	$2.052B
Trevi Therapeutics, Inc. (TRVI)	United States	$2.091B	-51.93
PALVELLA THERAPEUTICS, INC. (PVLA)	United States	$2.105B	-35.55